Geoffrey Grandjean

AD Article

Pharma Package – Deal at the EU level on a major pharma reform

The European Parliament and the Council of the EU have reached a provisional agreement on the Pharma Package, the most significant overhaul of EU pharmaceutical law in the past twenty years. The reform introduces a new directive and regulation that update regulatory data protection rules, expand the Bolar exemption, strengthen obligations on medicine supply and market continuity, and create a new transferable exclusivity voucher to incentivize priority antibiotic development. The agreement now awaits formal adoption before entering into force.

AD Article

Clarity On Knotty Patent Jurisdiction Questions From CJEU

Despite the emergence of the Unified Patent Court in 2023, with jurisdiction over 18 of the 27 European Union member states for both infringement and validity, the national patent courts in the EU retain a competitive jurisdiction.

AD Article

Sony Court of Cassation ruling of April 24, 2024: admissibility of infringement claims even for events occurring prior to registration of the assignment.

Registration of the assignment in the National Patent Register (NPR) enables the assignee of a patent to enforce the assigned patent against third parties

AD Article

Recasting the existing EU SPC regulations and introducing a unitary SPC: recent progress and future steps

La Commission européenne a proposé une réforme des Certificats Complémentaires de Protection (CCP) pour les médicaments, avec un CCP unitaire et une refonte du règlement existant. Le Parlement européen a adopté ces textes le 28 février dernier. L'EUIPO examinera les demandes de CCP, avec des mécanismes de contrôle et de recours. Les textes intègrent la jurisprudence de la CJUE pour assurer la cohérence. Les prochaines étapes incluent des discussions avec le Conseil de l'Union européenne dans le cadre des trilogues. Les élections européennes ne devraient pas interrompre le processus législatif.